Question explored with the scientific record
Folic acid
Folic acid is one of the few supplements with strong randomized-trial proof of benefit, but the benefit is specific: it prevents neural tube defects around conception. Beyond that, the evidence thins and the harms are real at high doses.
The core proof comes from randomized trials. Periconceptional folic acid prevented up to about 70% of neural tube defects in the MRC and Hungarian trials [2], and the Hungarian trial of a 0.8 mg multivitamin showed roughly a 90% reduction in first occurrence [3]. Population data back this: after mandatory fortification, neural tube defects fell about 19% in the US and roughly 50% in Canada and Chile [2], with 30–50% drops reported across the two countries [1]. Dose matters: a randomized dose-finding trial estimated about a 47% risk reduction at 400 mcg daily versus 22% at 100 mcg [6]. Recurrence prevention in high-risk couples used 4 mg daily, cutting repeat defects by 72% [5]. Timing is the catch: reaching protective red-cell folate takes roughly 20 weeks, so starting at pregnancy confirmation is often too late [4].
The harms are not hypothetical. A meta-analysis of 10 randomized trials found no benefit and a borderline increase in overall cancer with supplementation, prostate cancer the only site-specific signal [1]. A 2022 systematic review found nearly all women in fortified countries who take supplements exceed the 1000 mcg upper tolerable limit [8], and excess intake can mask B12 deficiency [9]. High-dose folic acid above 2.5 mg daily reduced antifolate malaria drug efficacy [7]. For preeclampsia, the evidence is mixed: one trial found no difference between 1 mg and 5 mg [10], while a large Chinese cohort associated supplementation with lower risk [11]. Continued supplementation past the first trimester was linked to larger-for-gestational-age babies in one cohort [12].
| Setting | Finding | Source |
|---|---|---|
| NTD prevention, RCTs | up to ~70% prevented | [2] |
| NTD, 400 mcg dose trial | ~47% risk reduction | [6] |
| Fortification, US/Canada | 19–50% fewer NTDs | [2] |
| Cancer, meta-analysis of 10 RCTs | borderline increased risk | [1] |
| Supplement users in fortified countries | nearly all exceed 1000 mcg UL | [8] |
My call: for women planning pregnancy, folic acid before conception is one of the best-evidenced interventions in medicine; for everyone else, high-dose or indefinite supplementation is not supported and carries plausible cancer and B12-masking risks. Confidence: high on pregnancy benefit, moderate on the harms.
Sources used 12
-
Folic acid fortification prevents neural tube defects and may also reduce cancer risks
This review argues that mandatory folic acid fortification effectively prevents neural tube defects and that cancer-risk concerns are not supported at physiological intake levels, recommending EU implementation soon.
DOI: 10.1111/j.1651-2227.2012.02781.x -
Mandatory Fortification of Flour with Folic Acid to Prevent Neural-Tube Defects
Commentary advocating mandatory folic acid fortification of flour to prevent neural-tube defects, citing evidence of 19–50% prevalence reductions in implementing countries and emphasizing the need for well-resourced monitoring programs.
DOI: 10.2217/17455057.3.3.309 -
Periconceptional Folic Acid-Containing Multivitamin Supplementation for the Prevention of Neural Tube Defects and Cardiovascular Malformations
Periconceptional folic acid-containing multivitamin supplementation reduces the risk of neural tube defects and cardiovascular malformations, with evidence from randomized and observational trials supporting approximately 40% efficacy for CVM prevention.
DOI: 10.1159/000332125 -
Prevention of Fetal Neural Tube Defect with Folic Acid Supplementation
Periconceptional folic acid supplementation, aiming to raise red-blood-cell folate to about 1050–1340 nmol/L with around 4 mg daily for roughly 20 weeks before conception, reduces neural tube defect risk, but residual risk remains and global compliance with fortification and sup…
DOI: 10.47895/amp.v56i5.5539 -
Prevention of Birth Defects: Folic Acid
Periconceptional folic acid reduces neural tube defect recurrence and incidence; higher compliance magnifies the population impact.
DOI: 10.1177/109980040100300105 -
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects
This study investigates the minimum effective dose of folic acid required to prevent neural-tube defects (NTD) by conducting a randomized trial with varying doses of folic acid supplementation among women with suboptimal red-cell folate levels.
DOI: 10.1016/s0140-6736(97)07247-4 -
Malaria in the Era of Food Fortification With Folic Acid
This narrative review concludes that high folate status may promote malaria parasite growth and reduce antifolate drug efficacy, but the evidence is mixed and folate deficiency may sometimes favor malaria.
DOI: 10.1177/0379572116634511 -
Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review
Women of childbearing age in countries with mandatory folic acid fortification do not obtain sufficient folate from food alone, but nearly all who take folic acid supplements exceed the 1000 mcg upper tolerable limit.
DOI: 10.3390/nu14132715 -
Gebelikte Folik Asit, B12 Vitamini, D Vitamini ve İyot Destekleri Kullanmak Gerekli Midir? Olası Riskler
Excessive intake of folic acid, vitamin B12, vitamin D, and iodine during pregnancy may increase risks including carcinogenicity, masked B12 deficiency, teratogenicity, and thyroid dysfunction; supplementation should thus be individualized.
DOI: 10.17517/ksutfd.832401 -
Comparison of high dose and low dose folic acid supplementation on prevalence, onset and severity of preeclampsia
This randomized trial found no evidence that 5 mg folic acid, compared with 1 mg, reduced preeclampsia severity or altered preeclampsia onset.
DOI: 10.4103/2277-9175.190944 -
Folic acid supplementation and dietary folate intake, and risk of preeclampsia
A birth cohort study in Lanzhou, China, found that folic acid supplementation before and/or during pregnancy and higher dietary folate intake during pregnancy are associated with a reduced risk of preeclampsia, with effects that vary by severity and onset.
DOI: 10.1038/ejcn.2014.295 -
Maternal Continuing Folic Acid Supplementation after the First Trimester of Pregnancy Increased the Risk of Large-for-Gestational-Age Birth: A Population-Based Birth Cohort Study
In a Chinese prospective cohort of 2,644 women, continued folic acid supplementation after the first trimester was associated with larger birth size and higher LGA prevalence, but not with significant differences in SGA, LBW, or HBW.
DOI: 10.3390/nu8080493